Other Industry News

Chinese Pharmaceutical Firm GZ Bailing Group Pharm. Agrees to Back Herbal Medicine Maker

Chinese pharmaceutical firm GZ Bailing Group Pharm. Co. [SHE:002424] said in a statement that it will boost an herbal medicine company’s competitiveness by investing in it. The Anshun-based grou... Full Story

Celltrion Envisions Remsima Plant in China

Celltrion is set to move in to the Chinese market. Remsima, a biosimilar medicine effective for the treatment of patients with rheumatoid arthritis and ulcerative colitis. The company announced on May 24... Full Story

RepliCel CEO Provides Company Outlook

, a regenerative medicine company addressing large-market opportunities with innovative technologies in aesthetics and sports injury/orthopedics, today unveiled its go-forward strategy. In the first few m... Full Story

WuXi Biologics guns for $500M Hong Kong IPO

The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong. According to Thomson Reuters, quoting anonymous people "close to the deal,” the... Full Story

Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices

, a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that two additional Chinese, tier 1 positron emission tomography (PET) OEM integ... Full Story

Frontline BioVentures, WuXi Healthcare To Merge, Creating $800M Fund

Two Chinese venture firms, Frontline BioVentures and WuXi Healthcare Ventures, have agreed to merge to form one healthcare investment group named 6 Dimensions Capital, in a rare case of two venture firms... Full Story

WuXi NextCODE In Hunt For $200 Million In Venture Capital

According to a Reuters report, WuXi NextCODE is talking to investors about another fundraising, this one for $200 million. The company, which is part of WuXi AppTec's genomics operation, completed a ... Full Story

VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update

today announced financial results for the quarter ended March 31, 2017 and provided a business update. Cameron Reynolds, President and Chief Executive Officer of Volition, said, "I am delighted with ... Full Story

A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays

 today announced the publication of a research paper entitled "Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer". The study was published in C... Full Story

Sequoia Leads $10M Round In Medical Artificial Intelligence Start-Up VoxelCloud

Sequoia Capital has led a US$10 million series A round in VoxelCloud, a Los Angles-based artificial intelligence start-up with two Chinese co-founders providing automated medical image analysis services.... Full Story

Company Search

Upcoming Events More